Management Board meeting: 16-17 March 2011
Date:
16/03/2011 to 17/03/2011
Location:
European Medicines Agency, London, UK
The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance.
-
List item
Minutes of the 70th meeting of the Management Board: 16-17 March 2011 (PDF/228.02 KB)
Adopted
First published: 27/05/2011
Last updated: 27/05/2011
EMA/MB/232704/2011 -
-
List item
Presentation - Session 2: What can already be improved following the evaluation of the Agency and the Network (without changing the legislation) (PDF/299.33 KB)
First published: 18/07/2011
Last updated: 18/07/2011 -
List item
Presentation - Health Technology Assessment: Impact on Regulators (PDF/1.46 MB)
First published: 18/07/2011
Last updated: 18/07/2011 -
List item
Agenda for the 70th meeting of the Management Board, 16–17 March 2011 (PDF/143 KB)
Adopted
First published: 29/03/2011
Last updated: 29/03/2011
EMA/MB/19969/2011 -
List item
Amendments to Management Board implementing rules on the Agency’s fees in relation to inflation and extrapolation of MRLs effective from 1 April 2011 - Management Board meeting 17 March 2011 (PDF/312.68 KB)
Adopted
First published: 29/03/2011
Last updated: 29/03/2011
EMA/MB/757388/2010 -
List item
Performance of the Agency’s scientific procedures: Survey 2010 for medicinal products for human use - Management Board meeting 17 March 2011 (PDF/543.01 KB)
First published: 29/03/2011
Last updated: 29/03/2011
EMA/MB/66833/2011 -
List item
Outcome of Management Board written procedures during the period from 25 November 2010 to 22 February 2011 - Management Board meeting 17 March 2011 (PDF/132.36 KB)
First published: 29/03/2011
Last updated: 29/03/2011
EMA/MB/105462/2011 -
List item
Summary of transfer of appropriations in the budget 2010 - Management Board meeting 17 March 2011 (PDF/114.99 KB)
First published: 29/03/2011
Last updated: 29/03/2011
EMA/MB/111120/2011